首页> 外文期刊>Stem cell research >Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations
【24h】

Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations

机译:从三个患有不同SCN1A基因突变的Dravet综合征的三名患者中产生三种人类诱导的多能干细胞(IPSC)系列

获取原文
           

摘要

Dravet syndrome (DS) is a childhood epilepsy syndrome caused by heterozygous mutations in the SCN1A gene encoding voltage-gated sodium channel Nav1.1. We generated iPSCs from fibroblasts of three DS patients carrying distinct SCN1A mutations (c.5502-5509dupGCTTGAAC, c.2965GC and c.651CG). The iPSC lines were genetically stable and each line retained the SCN1A gene mutation of the donor fibroblasts. Characterization of the iPSC lines confirmed expression of pluripotency markers, absence of exogenous vector expression and trilineage differentiation potential. These iPSC lines offer a useful resource to investigate the molecular mechanisms underlying Nav1.1 haploinsufficiency and for drug development to improve treatment of DS patients.
机译:Dravet综合征(DS)是一种儿童癫痫综合征,由编码电压门控钠通道Nav1.1的SCN1A基因中的杂合突变引起。我们从携带不同SCN1A突变的三次DS患者的成纤维细胞产生IPSC(C.5502-5509DupGCTTGAAC,C.965G> C和C.651C> G)。 IPSC线路遗传稳定,每根线保留供体成纤维细胞的SCN1A基因突变。 IPSC线的表征证实了多能性标志物的表达,不存在外源性载体表达和三螺素分化电位。这些IPSC系列提供了一种有用的资源,以研究Nav1.1臭氧水电质水能和药物开发的分子机制,以改善DS患者的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号